Back

Re-Booting Modern Treatment for Relapsed/Refractory Myeloma: Clinical Perspectives on Emerging Agents and Delivering Innovative Patient Care

Re-Booting Modern Treatment for Relapsed/Refractory Myeloma: Clinical Perspectives on Emerging Agents and Delivering Innovative Patient Care

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 credit

MOC types

ABIM — Medical KnowledgeUp to 1 pointABIM — Patient SafetyUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Commercial Support
  • Released
    Oct 7, 2026
  • Last day to claim credit
    Nov 7, 2027 1 year left